ERBB2 and gastric cancer: Intriguingly, SPOCK1 expression has been shown to induce EMT in multiple cancer cell lines, including gall bladder, lung, and esophagus, and has been demonstrated to confer resistance to HER2 target therapy in gastric cancer cell line through EMT [24–26,33].